Profile
Truffle Capital is a private equity and venture capital firm based in Paris, founded by a team of experienced business builders with deep expertise in finance and entrepreneurship. The firm is led by seasoned professionals with a strong track record in investment and business development. Truffle Capital differentiates itself through its dual focus on creating and nurturing early-stage companies in the fields of BioMedTech and Fintech.
The firm invests in sectors including Biotechnology, Fintech, and Medical Devices through different stages ranging from early to later stages. It typically commits between $5-10 million per investment. Truffle Capital has a comprehensive investment strategy across Europe, focusing on high-growth companies. The firm manages a significant amount of assets under management with funds aimed at generating long-term value.
Notable investments by Truffle Capital include companies such as Carmat - heart bioprostheses, Vexim - spine trauma, and Symetis - transcatheter valve technology. These portfolio companies reflect Truffle Capital's strategic approach towards breakthrough technologies and solutions in their fields.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.